MMS Holdings, a global, data-focused clinical research organization (CRO), today named UK-based Ben Dudley as President, extending his existing role as Chief Commercial Officer. The expanded position ...

"With encouraging momentum across both our LCA5 and BEST1 gene therapy programs, Opus Genetics is entering a defining stretch ...

Treatment with BH-30236, a novel CLK inhibitor, was generally well tolerated as monotherapy and in combination with venetoclax ...

Received regulatory clearance to initiate its Phase 1 clinical trial of IBIO-600 in AustraliaAnnounced a strategic pipeline expansion into ...

Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstracts have been accepted for oral presentations at the 2026 ...

Aims To evaluate whether predominantly peripheral lesions (PPLs) and other imaging biomarkers on ultra-widefield (UWF) ...

First-ever FDA approved PROTAC supports the further development and potential of Arvinas' pipeline - - Announced FDA Approval of VEPPANU (vepdegestrant) for the treatment of ESR1m, ER+/HER2- advanced ...

VergeIO, the Private Cloud Operating System company, today announced general availability of Kubernetes support in VergeOS. The release adds a CSI storage driver, Cloud Controller Manager, Cluster ...

International student enrolment in US colleges has seen a sharp fall, raising fresh concerns among universities that depend ...

Understood.org, a leading nonprofit supporting the 70 million people in the U.S. who have learning and thinking differences, ...

LENZ Therapeutics (NASDAQ:LENZ) reported first-quarter 2026 results that showed continued prescription growth for its ...